Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
If Mounjaro doesnt feel like the right option for you, and you don't want to try Wegovy, there are other weight loss treatments available
To minimize discomfort, try to inject slowly, and always rotate your injection sites
Prescription GLP-1 treatments have been tested in large, long-running clinical trials involving thousands of participants: Semaglutide 2.4 mg (Wegovy) participants lost an average of around 1521% of their body weight over 6872 weeks in the STEP trials Tirzepatide (Mounjaro) the SURMOUNT trials showed average weight loss of 2025% of starting body weight at the highest dose over 72 weeks These results come from rigorously controlled studies with safety monitoring, dose titration, and long-term follow-up
Month 1-2 : Reduced Hunger Participants in a clinical study using Supresa saffron extract showed 69% decreased hunger, 65% reduced sugar cravings and 55% decrease in snacking events in 8 weeks
2012 Salehi M, Aulinger B, Prigeon RL, et.al
Prior studies utilizing GLP-1 receptor agonists (e.g., liraglutide and semaglutide) in women with PCOS have demonstrated benefits in weight control, insulin resistance, and waist circumference, as well as signs of improved ovulatory regularity
